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The fate of an intracellular pathogen in mononuclear phagocytes appears to be an 
important  determinant  of the capacity of the pathogen  to cause disease. Antibody 
against  the  pathogen  can  markedly alter the  intracellular  fate of the  pathogen  in 
mononuclear phagocytes; such an effect of antibody is reflected in vivo by enhanced 
resistance to infection of animals that have been passively immunized with hyperim- 
mune  serum.  Under  these  conditions,  the  specific  immunity  expressed  by  these 
animals results from the presence of antibody and not from the presence of antigen- 
sensitive leukocytes. For example, antibody inhibited the intracellular multiplication 
of the obligate intracellular  parasite Rickettsia  mooseri in cultured  human monocytes 
and rendered the organism susceptible to killing by these monocytes (1);  paralleling 
this  in  vivo,  the  same  antibody  protected  passively  immunized  mice  against  an 
otherwise  lethal  infection  from  R.  mooseri ([1];  and  C.  L.  Wisseman, Jr.  Personal 
communication.).  Similarly,  human  and  mouse  antitoxoplasma antibody rendered 
the  obligate  intracellular  parasite  Toxoplasma  gondii  incapable  of  multiplying  in 
cultured human monocytes (2)  and mouse peritoneal macrophages (3), respectively; 
mouse  anti-toxoplasma  antibody  protected  passively  immunized  mice  from  lethal 
infection with T. gondii (4). 
With  other  intracellular  pathogens,  antibody  does not  significantly  inhibit  their 
multiplication in cultured leukocytes; this is reflected in vivo by a failure of antibody 
to protect passively immunized animals from infection. For example, immune mouse 
serum  did  not  inhibit  the  multiplication  of the  facultative intracellular  bacterium 
Listeria  monocytogenes in  cultured  mouse  peritoneal  macrophages  (5);  and  immune 
mouse serum did not protect mice from infection with L. monocytogenes (6).  Similarly, 
antibody did not inhibit the multiplication of the facuhative intracellular bacterium 
Mycobacterium tuberculosis in cultured  mouse, rabbit, or guinea pig peritoneal  macro- 
phages  (7-9);  and immune mouse serum did not influence the survival of mice nor 
did immune guinea pig serum influence the course of infection in guinea pigs when 
these animals were challenged with M. tuberculosis (10,  11). In all these studies, there 
is a  correlation between the capacity of antibody to inhibit intracellular infection of 
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mononuclear phagocytes in vitro and to protect the passively immunized host against 
infection with the same pathogen, i.e., the in vitro studies appear to accurately reflect 
the role of antibody in host defense against diseases caused by intracellular pathogens. 
Therefore, to define the role of antibody in Legionnaires' disease, which is caused by 
the  facultative intracellular bacterial pathogen  Legionella  pneumophila  (12),  we have 
studied the effect ofanti-L, pneumophila antibody on host cell-L, pneumophila interaction. 
In  the  accompanying  paper  (.13),  we  described  our  studies  on  the  influence  of 
antibody on  the interaction of L. pneumophila  with  human  serum  and  human  poly- 
morphonuclear leukocytes (PMN'). 1 We found that  virulent egg yolk-grown L. pneu- 
mophila bacteria are completely resistant to the bactericidal effects of human  serum 
whether or not the serum contains anti-L, pneurnophila  antibody. Moreover, we found 
that a  significant proportion (30-40%)  of an inoculum of L. pneumophila is resistant to 
killing by PMN even in the presence of anti-L, pneumophila antibody and complement. 
In this paper, we describe our studies on the effects of anti-L, pneumophila antibody 
on  the interaction of L. pneumophila  (Philadelphia  1 strain)  with  human  monocytes. 
We demonstrate (a) that anti-L, pneumophila antibody, in the presence of complement, 
promotes the binding of viable L. pneumophila  to monocytes, as it does to  PMN;  (b) 
that monocytes, like PMN, require both specific antibody and complement to kill any 
L  pneumophila  and  that,  under  these  conditions,  monocytes  kill  only  a  limited 
proportion of a bacterial inoculum; and (c) that L. pneumophila surviving the confron- 
tation with monocytes in the presence of specific antibody and complement multiply 
in  monocytes  as  rapidly as  when  the  bacteria  enter  monocytes  in  the  absence  of 
specific antibody. 
Materials  and  Methods 
Media, Agar, Sera, and Bacteria.  The media, agar, sera, and bacteria used in this study were 
obtained or prepared and stored as described in the accompanying paper (13). Normal human 
serum had an indirect fluorescent antibody (IFA) anti-L, pneumophila titer of< 1:64 and immune 
human serum had an IFA anti-L, pneumophila titer of 1:4,096  (13). 
Human  Blood Mononuclear Cells.  The  blood  mononuclear  cell  fraction  was  obtained  by 
centrifugation over a  Ficoll-sodium diatrizoate solution as previously described (12);  the cells 
were >99% viable by trypan blue exclusion. Examination of a stained cytocentrifuged sample 
revealed that the mononuclear cell fraction contained ~40% monocytes, 58.5%  lymphocytes, 
and  1.5% PMN. The adherent subpopulation (containing >90%  monocytes) and the nonad- 
herent subpopulation (containing >90% lymphocytes) were prepared as described (12). For use 
in  the  mononuclear  cell-killing assay  described below,  adherent  cells in  Petri  dishes were 
resuspended by incubating the cells for 10 min at 4°C (which causes most cells to round-up and 
many  to detach)  and  gently scraping them  off the bottom of the Petri dish with a  rubber 
policeman. Recovered cells were 90% viable by trypan blue exclusion. 
Mononuclear Cell-killing Assay.  This was identical to the PMN-killing assay described in the 
accompanying paper (13) except that instead of PMN, 2 X  106 or 5 X  108 mononuclear cells, 
2 X  10  resuspended adherent mononuclear cells, or 2 X  106 nonadherent  mononuclear cells 
were incubated with L. pneurnophila. At the end of the incubation, the contents of each tube 
were sonicated for 60 sec continuously with a micro-tip attached to a sonicator (Heat Systems- 
Ultrasonics, Inc., Plainview, N. Y.) with the output control of the sonicator set at the 4 position; 
this amount of sonic energy lysed the mononuclear cells completely but did not reduce bacterial 
colony-forming units (CFU) (12). 
Assay for the Binding of Viable L. pneumophila to Monocytes in the Presence or Absence of Anti-L. 
pneumophila Antibody.  L. pneumophila (2.5  X  105 CFU/ml) were incubated in plastic test tubes 
I Abbreviations used in this paper: CFU, colony-forming units;  IFA, indirect  fluorescent antibody assay; 
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for 15 min at 37°C in 5.5 ml of medium that contained 30% fresh normal human serum or 30% 
fresh immune human serum. 1-ml quantities of these bacterial suspensions were then immedi- 
ately transferred to 35-ram Petri dishes containing freshly prepared monocyte monolayers in 1 
ml of RPMI-1640 medium (Gibco Laboratories, Grand Island Biological Co., Grand Island, 
N. Y.) (~2 ×  106 monocytes/Petri dish); the final vol in each Petri dish was 2 ml and the final 
serum concentration was  15%. Monocyte monolayers were incubated with bacteria for 1 h at 
37°C in 5% CO~-95% air on a gyratory shaker at 100 rpm. After the incubation, the monocyte 
monolayers were washed vigorously three times with RPMI-1640 (at 37°C) to remove non-cell- 
associated bacteria. Then 2 ml of RPMI-1640 was add6d to each Petri dish. The monocyte 
monolayers were then sonicated with a 2.54-cm-diam high-gain disrupter horn, attached to a 
sonieator (Heat Systems-Ultrasonics, Inc.) under sterile conditions with the output control of 
the sonicator set  at the 4 position; this amount of sonic energy lysed  the mononuclear cells 
completely but did not reduce bacterial CFU (12). CFU of L. pneumophila in each Petri dish 
were determined. Five Teplicate Petri dishes were used for each measurement. 
Infection of Mononuclear Cells in Suspension or Monocytes m a Monolayer in the Presence of Anti-L. 
pneumophila Antibody.  In the experiment depicted in Fig. 2, L. pneumophila (5 ×  104 CFU) were 
incubated at 37°C for 15 min in plastic test  tubes in 750/.tl of medium that contained 250/~1 
of fresh  normal human serum  or  250  #1  of fresh  immune human serum.  Then  5  X  106 
mononuclear ceils (or RPMI-1640 as control) were added and the final vol in each tube was 
brought to 2.5 ml with RPMI-1640; the final serum concentration was  10%. A  100-/~1 sample 
from each tube was immediately removed and assayed for CFU of L. pneumophila on modified 
charcoal yeast extract agar as described (12). The tubes were then gassed  to a pH of 7.4 with 
5% CO2-95% air, sealed, and incubated for  1 h  at  37°C on a  gyratory shaker at  250 rpm. 
Immediately after the incubation and at 24-h intervals for 4 d thereafter, the medium in each 
tube was assayed for CFU ofL. pneumophila. Five replicate tubes were used for each measurement. 
In the experiment depicted in Fig. 3, monocyte monolayers were infected in the presence of 
normal or immune serum exactly as in the assay for the binding of viable L. pneurnophila to 
monocytes described above except that the concentration of bacteria preincubated with 30% 
normal or  30%  immune serum was  106 CFU/ml instead of 2.5  ×  105  CFU/ml. After the 
monolayers were infected, Petri dishes were divided into two sets. Monocyte monolayers in the 
first  set of Petri dishes  (five that contained normal and five that contained immune serum) 
were  washed  vigorously three  times with  RPMI-1640  (at  37°C)  to  remove non-monocyte- 
associated bacteria and the cells were reincubated in 2 ml RPMI-1640 and 15% serum of the 
same type to which they had  initially been exposed~ The monolayers in two of these  Petri 
dishes (one containing  immune serum and in one containing  normal serum) were then sonically 
disrupted, as in the binding assay,  to determine the total number of CFU of L. pneumophila 
initially in these cultures. Monocyte monolayers in the second set  of Petri dishes (four that 
contained immune and four that  contained normal serum)  were  not  washed  free  of non- 
monocyte associated bacteria. The remaining eight Petri dishes in the first set and the eight 
Petri  dishes  in the second set  were incubated at  37°C in 5% CO2-95% air under stationary 
conditions. The medium in each Petri dish was assayed for CFU of L. pneumophila at the start 
of this incubation period and daily for 4 d thereafter. Four replicate Petri dishes were used for 
each measurement in Fig. 3. 
Results 
Monocytes Require Both Specific Antibody and Complement to Kill Any L. pneumophila.  We 
incubated mononuclear cells  with  L.  pneumophila  in  the  presence  of fresh  normal 
human serum (a source of complement), heat-inactivated immune human serum (a 
source of anti-L, pneumophila  antibody), or fresh immune human serum (a source of 
both antibody and complement). Mononuclear cells killed L. pneumophila only when 
both a source of antibody and complement were present (Fig. 1 A). The mononuclear 
cells reduced CFU of L. pneumophila by only 0.25 log (45%). 
In separate experiments, we  incubated L.  pneumophila  with  2  ×  106  lymphocytes 
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Ftc.  1.  Monocyte  killing  of L. pneumophila. (A)  Mononuclear cells  require  both  antibody  and 
complement to kill any L. pneumophila. Mononuclear cells  (5 ×  l0  n) were incubated with 2.5 X  105 
(2FU of L. pneumophila at  37°(2  in 5% CO2-95%  air on a  gyratory shaker for  1 h  in medium that 
contained  10% fresh normal human serum (with an indirect fluorescent antibody assay (IFA) anti- 
L. pneumophila titer of <1:64),  10%  fresh immune human serum (with an IFA anti-L, pneumophila 
titer of 1:4,096),  or  10% heat-inactivated  immune human serum (HI immune serum). (2FU were 
determined initially and at the end of the incubation. Each point represents the average for three 
replicate tubes 4- SE (B)  Monocytes but not lymphocytes kill L. pneumophila. L. pneumophila (7.5 × 
6  6  10  s CFU)  were incubated  with 2  ×  10  lymphocytes (nonadherent mononuclear cells),  2  ×  10 
6  o  monocytes (adherent mononuclear cells), or 2 ×  10  mononuclear cells at 37  (2 in 5% (202-95%  air 
on a gyratory shaker for 1 h in medium that contained 10% fresh immune human serum. Adherent 
and  nonadherent mononuclear ceils  were selected  as described  in  Materials  and  Methods. (2FU 
were determined initially and at the end of the incubation. Each point represents the average for 
three replicate tubes 4- S.E. 
2 X  106 mononuclear cells in the presence of fresh immune human serum. Monocytes 
and mononuclear cells killed L. pneumophila (by 0.5 log and 0.25 log, respectively) but 
lymphocytes did not kill L. pneumophila (Fig.  1 B). This indicates that the monocytes 
in the mononuclear cell fraction are responsible for the killing. 
Thus, monocytes, like PMN, require both specific antibody and complement to kill 
any  L.  pneumophila;  even  then  they  kill  only  a  limited  proportion  of a  bacterial 
inoculum. 
Specific  Antibody Promotes the  Binding  of  Viable L.  pneumophila  to  Monocytes.  We 
preincubated L. pneumophila in medium that contained fresh normal or fresh immune 
human  serum  for  15  rain  at  37°C  and  then  further  incubated  the  bacteria  with 
monocyte monolayers for  1 h  at  37°C  as described  in  Materials  and  Methods.  We 402  OPSONIZED LEGIONELLA PNEUMOPHILA MULTIPLIES IN  MONOCYTES 
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Fro.  2.  Specific  antibody  fails to inhibit  the  multiplication  of L. pneumophila in  monocytes. L. 
pneumophila (2.5 ×  104 CFU) were incubated at 37°C for I0 min in 33% fresh normal human serum 
or 33% fresh immune human serum. The bacteria were then incubated at 37°C in 5% CO2-95% air 
with  5 ×  l0  s mononuclear  cells (or  RPMI-1640 as  control)  in  medium  that  contained  a  final 
concentration of 10% of the same type of serum to which the bacteria were initially exposed. The 
cultures were shaken for 1 h and  incubated  under stationary conditions thereafter  for 4 d. CFU 
were determined at 0,  1, 24, 48, 72, and 96 h after infecting the monocytes. Each point represents 
the average for five  replicate tubes + SE. 
then  sonicaUy  disrupted  the  monolayers  and  assayed  for  CFU  of L.  pneumophila. 
Monocyte monolayers incubated with L. pneumophila in the presence of normal serum 
contained an average of 2,490 ___  120 CFU of L. pneumophila (average for five replicate 
Petri  dishes  ±  SE).  Monocyte  monolayers  incubated  with  an  equal  number  of L. 
pneumophila in  the presence of immune serum  contained  an  average of 8,290  +  440 
CFU of L. pneumophila, 3.3 times as many viable bacteria as when anti-L, pneumophila 
antibody  was  absent.  Thus,  specific  antibody  promotes  the  binding  of  viable  L. 
pneumophila to monocytes as it does to PMN. 
Specific Antibody Does Not Inhibit the Multiplication of L. pneumophila in Monocytes.  We 
preincubated L. pneumophila in medium that contained fresh normal or fresh immune 
human  serum  for  15  rain  at  37°C  and  then  further  incubated  the  bacteria  with 
mononuclear cells for 4 d.  During the  1st h  of incubation with the mononuclear cells, 
the cultures were shaken on a  gyratory shaker;  thereafter they were incubated under 
stationary  conditions.  Serum  of  the  same  type  to  which  the  L.  pneumophila  were 
initially exposed was present  throughout. 
During the  1st  h  of incubation with mononuclear cells, the number of CFU of L, 
pneumophila  in  cultures  that  lacked  specific  antibody  remained  constant.  However, 
CFU  decreased  0.25  log in  cultures  that  contained  specific antibody  (Fig.  2).  This 
amount  of killing was  comparable  to  that  observed in  the  experiments depicted  in MARCUS  A.  HORWITZ  AND  SAMUEL  C.  SILVERSTEIN  403 
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FIo.  3.  Monocyte-adherent bacteria coated with antibody and complement multiply in monocytes. 
L. pneumophila (106 CFU) were preincubated with fresh immune or fresh normal human serum for 
15  min  at  37°C,.and  further incubated  for  1 h  at  37°C  on  a  gyratory shaker  with  monocyte 
monolayers in Petri dishes (~2 X  10  s monocytes/Petri dish) containing 2 ml RPMI-1640 and  15% 
of the same type of serum to which they were initially exposed. Some of the monocyte monolayers 
were then washed to remove nonmonocyte associated bacteria and reincubated in 2 ml RPMI-1640 
and  15% serum of the same type to which they were initially exposed. The medium in each Petri 
dish was assayed daily for CFU of L. pneumophila. Points on the lines labeled "Adherent bacteria" 
(C)  O)  represent CFU of L. pneumophila in the  medium of monocyte monolayer cultures that 
were washed to remove non-monocyte-associated bacteria. Separate measurements showed that, at 
the start of the final incubation (0 d  after infection on this graph), 98 and 86% of the bacteria in 
these cultures incubated in the presence of immune and normal serum, respectively, were monocyte 
associated. Points on the lines labeled "Adherent and nonadherent bacteria" (0) represent CFU of 
L. pneumophila in the medium of monocyte monolayer cultures that were not washed to remove non- 
monocyte-associated bacteria.  Each  point represents the average for four replicate  Petri  dishes ± 
SE. 
Fig.  1.  Subsequently,  the  number  of CFU  in  cultures  with  and  without  specific 
antibody changed in parallel, first  decreasing slightly and then increasing three logs. 
To confirm that monocyte-associated  bacteria coated with antibody and comple- 
ment are capable of multiplying and initiating a cycle of infection in monocytes, and 
to study the growth  kinetics  of opsonized L. pneumophila in cultures  that contained 
only monocytes,  we  did  the  following experiment.  We  preincubated  L. pneumophila 
with  fresh  normal  or  fresh  immune  human  serum  for  15  min  at  37°C,  further 
incubated them with monocyte monolayers for  1 h, and washed some of the mono- 
layers  to  remove  non-monocyte-associated  bacteria,  as  described  in  Materials  and 
Methods. To determine the total number of CFU of L. pneumophila present in cultures 
after  the  non-monocyte-associated  bacteria  had  been  washed  away,  we  sonically 404  OPSONIZED LEGIONELLA  PNEUMOPHILA  MULTIPLIES  IN  MONOCYTES 
disrupted  the  monolayers  in  two  Petri  dishes  and  assayed  for  CFU.  We  further 
incubated the remaining cultures and assayed the culture medium of these cultures 
for CFU of L. pneumophila at the start of this incubation and daily for 4 d thereafter. 
Cultures that  had  been incubated  for  1 h  with L. pneumophila in  the presence of 
fresh immune and fresh normal human serum contained 14,100  and 3,800 CFU/ml, 
respectively, after the cultures were sonically disrupted; a ratio of 3.7:1. This ratio is 
similar to the 3.3:1 ratio observed in the binding study discussed above. After washing 
away the bacteria, there were 300 CFU/ml in the medium of cultures that contained 
intact monolayers and immune serum (Fig. 3). Because there were 14,100 CFU/ml in 
a replicate culture containing a sonically disrupted monolayer, ~98% of the bacteria 
in  the  cultures  containing  intact  monolayers and  immune  serum  were  monocyte- 
associated  at  the  end  of a  1-h  incubation  period,  i.e.,  at  the start  (day 0)  of the 
infection as shown in Fig. 3. 
L. pneumophila multiplied to high levels in cultures initially containing only adherent 
bacteria and in cultures initially containing both adherent and nonadherent bacteria, 
whether or not antibody was present (Fig. 3). The rates of multiplication were similar 
in all cultures. We have obtained similar results in another experiment of this type in 
which we used dialyzed rabbit anti-L, pneumophila antiserum plus fresh normal human 
serum as the source of antibody and complement. In the accompanying paper, we 
showed that L. pneumophila incubated for 15 min at 37°C in immune serum are coated 
with  antibody and  complement  (13).  Therefore, opsonized L. pneumophila bacteria 
bound  to monocytes in  the  presence of antibody and  complement are capable of 
multiplying and initiating a cycle of infection in monocytes and of doing so as rapidly 
as unopsonized bacteria. 
In  all  of these  experiments, the  peak  level of L. pneumophila growth  attained  in 
cultures containing specific antibody was 0.25-0.5  log less  than  in cultures lacking 
specific antibody (Figs.  2 and 3). We do not know why this was so. 
Thus, when monocytes are incubated with L. pneumophila in the presence of specific 
antibody and  complement,  the  leukocytes kill  a  small  proportion of the  bacteria; 
however, the surviving bacteria multiply in monocytes as rapidly as when the bacteria 
are not exposed to antibody. 
Discussion 
PMN and monocytes have similar requirements for killing L. pneumophila in that 
they require anti-L, pneumophila antibody and complement; antibody and complement 
increase the binding of viable bacteria to PMN and monocytes (5). In this respect, the 
interaction of PMN and monocytes with L. pneumophila resembles the interaction of 
these  leukocytes with  eficapsulated  bacteria  (14).  However, whereas  encapsulated 
Escherichia coli are highly susceptible to the bactericidal effects of  phagocytic leukocytes 
(14), L. pneurnophila are relatively resistant to killing by PMN and monocytes. In their 
interaction with L. pneumophila, PMN and monoeytes differ from each other in that 
only monocytes support the intraeellular multiplication of L. pneumophila (12,  13). 
The experiments reported here and  in  the  accompanying paper  (13)  show  that 
antibody and complement fail to bring about two major biological effects, at least in 
vitro.  First,  they  fail  to promote  effective killing  of L.  pneumophila by  PMN  and 
monocytes. Second, they fail to inhibit  the growth of L. pneumophila in  monocytes. 
Although  our  findings  do  not  exclude  a  role  for  antibody  and  complement  in MARCUS A.  HORWITZ AND SAMUEL (2.  SILVERSTEIN  405 
conjunction  with cell-mediated immunity, they suggest  that  humoral  immunity by 
itself may not  be an  effective host  defense against  L. pneumophila;  consequently,  a 
vaccine that resulted only in antibody production against  the Legionnaires' disease 
bacterium may not be efficacious. 
These  results  are consistent  with  our previous  suggestion  that  cell-mediated  im- 
munity plays an important role in host defense against L. pneumophila  (4). 
Summary 
In  an  accompanying  paper  (13),  we  reported  that  human  polymorphonuclear 
leukocytes  kill  only  a  limited  proportion  (0.5  log)  of  an  inoculum  of Legionella 
pneumophila  (Philadelphia  1  strain)  in  the  presence  of human  anti-L,  pneumophila 
antibody and complement. We now report on the effect of anti-L, pneumophila antibody 
on L. pneumophila-monocyte interaction. The studies were carried out under antibiotic- 
free conditions. 
Monocytes bind more than  three times as many viable L. pneumophila  bacteria in 
the presence of both antibody and complement than in the presence of complement 
alone. Monocytes require both antibody and complement to kill any L. pneumophila: 
however,  even  then,  monocytes  kill  only  a  limited  proportion  (0.25  log)  of  an 
inoculum. The surviving bacteria multiply several logs in the monocytes and multiply 
as rapidly as when the bacteria enter monocytes in the absence of antibody. 
These findings suggest that humoral immunity may not be an effective host defense 
against L. pneumophila.  Consequently,  a  vaccine that  resulted  only in antibody pro- 
duction against the Legionnaires' disease bacterium may not be efficacious. 
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